TY - JOUR
T1 - Trigger values for investigation of hormonal activity in drinking water and its sources using CALUX bioassays
AU - Brand, W.
AU - de Jongh, C.M.
AU - Linden, S.C.
AU - Mennes, W.
AU - Puijker, L.M.
AU - van Leeuwen, C.J.
AU - van Wezel, Annemarie
AU - Schriks, M.
AU - Heringa, M.B.
PY - 2013
Y1 - 2013
N2 - To screen for hormonal activity in water samples, highly sensitive in vitro CALUX bioassays are available which allow detection of estrogenic (ERα), androgenic (AR), progestagenic (PR), and glucocorticoid (GR) activities. This paper presents trigger values for the ERα, AR, PR, and GR CALUX bioassays for agonistic hormonal activities in (drinking) water, which define a level above which human health risk cannot be waived a priori and additional examination of specific endocrine activity may be warranted. The trigger values are based on 1) acceptable or tolerable daily intake (ADI/TDI) values of specific compounds, 2) pharmacokinetic factors defining their bioavailability, 3) estimations of the bioavailability of unknown compounds with equivalent hormonal activity, 4) relative endocrine potencies, and 5) physiological, and drinking water allocation factors. As a result, trigger values of 3.8 ng 17β-estradiol (E2)-equivalents (eq)/L, 11 ng dihydrotestosterone (DHT)-eq/L, 21 ng dexamethasone (DEX)-eq/L, and 333 ng Org2058-eq/L were derived. Benchmark Quotient (BQ) values were derived by dividing hormonal activity in water samples by the derived trigger using the highest concentrations detected in a recent, limited screening of Dutch water samples, and were in the order of (value) AR (0.41) > ERα (0.13) > GR (0.06) > PR (0.04). The application of trigger values derived in the present study can help to judge measured agonistic hormonal activities in water samples using the CALUX bioassays and help to decide whether further examination of specific endocrine activity followed by a subsequent safety evaluation may be warranted, or whether concentrations of such activity are of low priority with respect to health concerns in the human population. For instance, at one specific drinking water production site ERα and AR (but no GR and PR) activities were detected in drinking water, however, these levels are at least a factor 83 smaller than the respective trigger values, and therefore no human health risks are to be expected from hormonal activity in Dutch drinking water from this site.
AB - To screen for hormonal activity in water samples, highly sensitive in vitro CALUX bioassays are available which allow detection of estrogenic (ERα), androgenic (AR), progestagenic (PR), and glucocorticoid (GR) activities. This paper presents trigger values for the ERα, AR, PR, and GR CALUX bioassays for agonistic hormonal activities in (drinking) water, which define a level above which human health risk cannot be waived a priori and additional examination of specific endocrine activity may be warranted. The trigger values are based on 1) acceptable or tolerable daily intake (ADI/TDI) values of specific compounds, 2) pharmacokinetic factors defining their bioavailability, 3) estimations of the bioavailability of unknown compounds with equivalent hormonal activity, 4) relative endocrine potencies, and 5) physiological, and drinking water allocation factors. As a result, trigger values of 3.8 ng 17β-estradiol (E2)-equivalents (eq)/L, 11 ng dihydrotestosterone (DHT)-eq/L, 21 ng dexamethasone (DEX)-eq/L, and 333 ng Org2058-eq/L were derived. Benchmark Quotient (BQ) values were derived by dividing hormonal activity in water samples by the derived trigger using the highest concentrations detected in a recent, limited screening of Dutch water samples, and were in the order of (value) AR (0.41) > ERα (0.13) > GR (0.06) > PR (0.04). The application of trigger values derived in the present study can help to judge measured agonistic hormonal activities in water samples using the CALUX bioassays and help to decide whether further examination of specific endocrine activity followed by a subsequent safety evaluation may be warranted, or whether concentrations of such activity are of low priority with respect to health concerns in the human population. For instance, at one specific drinking water production site ERα and AR (but no GR and PR) activities were detected in drinking water, however, these levels are at least a factor 83 smaller than the respective trigger values, and therefore no human health risks are to be expected from hormonal activity in Dutch drinking water from this site.
KW - Estrogens
KW - Endocrine disrupting compounds
KW - Androgens
KW - Glucocorticoids
KW - Progestogens
KW - In vitro bioassays
U2 - 10.1016/j.envint.2013.02.003
DO - 10.1016/j.envint.2013.02.003
M3 - Article
SN - 0160-4120
VL - 55
SP - 109
EP - 118
JO - Environment international
JF - Environment international
IS - May 2013
ER -
